Copper Imbalance in Alzheimer’s Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants
暂无分享,去创建一个
A. Albanese | G. Koch | G. Binetti | B. Borroni | I. Simonelli | S. Sensi | R. Squitti | L. Benussi | R. Ghidoni | M. Ventriglia | Alfredo Costa | C. Bonvicini | M. Rongioletti | G. Perini
[1] R. Squitti,et al. Agricultural Use of Copper and Its Link to Alzheimer’s Disease , 2020, Biomolecules.
[2] N. Hooper,et al. Evidence that levels of nine essential metals in post-mortem human-Alzheimer's-brain and ex vivo rat-brain tissues are unaffected by differences in post-mortem delay, age, disease staging, and brain bank location. , 2020, Metallomics : integrated biometal science.
[3] A. Bush,et al. Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathology , 2020, Neurobiology of Disease.
[4] R. Squitti,et al. Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic , 2019, Coordination Chemistry Reviews.
[5] M. Provinciali,et al. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis. , 2019, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[6] R. Squitti,et al. Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein. , 2019, Metallomics : integrated biometal science.
[7] M. Kitazawa,et al. Copper-Induced Upregulation of MicroRNAs Directs the Suppression of Endothelial LRP1 in Alzheimer's Disease Model. , 2019, Toxicological sciences : an official journal of the Society of Toxicology.
[8] Alzheimer's Association∗. 2019 Alzheimer's disease facts and figures , 2019, Alzheimer's & Dementia.
[9] S. Lovestone,et al. Pattern of Altered Plasma Elemental Phosphorus, Calcium, Selenium, Iron and Copper in Alzheimer’s Disease , 2018 .
[10] S. Sensi,et al. Copper and Zinc Dysregulation in Alzheimer's Disease. , 2018, Trends in pharmacological sciences.
[11] O. Bandmann,et al. Animal models of Wilson disease , 2018, Journal of neurochemistry.
[12] S. Patassini,et al. Plasma metals as potential biomarkers in dementia: a case–control study in patients with sporadic Alzheimer’s disease , 2018, BioMetals.
[13] M. Purushottam,et al. Lower levels of serum copper in patients with Alzheimer's dementia: A controlled study from India. , 2018, Asian journal of psychiatry.
[14] M. Tomás,et al. Oxidative stress and the amyloid beta peptide in Alzheimer’s disease , 2017, Redox biology.
[15] Zhan-You Wang,et al. Serum Copper, Zinc, and Iron Levels in Patients with Alzheimer's Disease: A Meta-Analysis of Case-Control Studies , 2017, Front. Aging Neurosci..
[16] N. Colabufo,et al. Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II) , 2017, Clinical chemistry and laboratory medicine.
[17] S. Patassini,et al. Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia. , 2017, Metallomics : integrated biometal science.
[18] R. Kukreti,et al. Multifactorial Analysis of a Biomarker Pool for Alzheimer Disease Risk in a North Indian Population , 2017, Dementia and Geriatric Cognitive Disorders.
[19] K. P. Kepp,et al. Ten Challenges of the Amyloid Hypothesis of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[20] Jianzhong Han,et al. The effect of copper from water and food: changes of serum nonceruloplasmin copper and brain's amyloid-beta in mice. , 2016, Food & function.
[21] L. Birnbaum,et al. Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[22] Oto Miedico,et al. Distinctive Pattern of Serum Elements During the Progression of Alzheimer’s Disease , 2016, Scientific Reports.
[23] Karl Herrup,et al. The case for rejecting the amyloid cascade hypothesis , 2015, Nature Neuroscience.
[24] J. Quinn,et al. Modulation of tau phosphorylation by environmental copper , 2014, Translational Neurodegeneration.
[25] P. Passmore,et al. Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies. , 2014, Journal of Alzheimer's disease : JAD.
[26] R. Squitti,et al. Low-copper diet as a preventive strategy for Alzheimer's disease , 2014, Neurobiology of Aging.
[27] Ashley I. Bush,et al. Dietary and lifestyle guidelines for the prevention of Alzheimer's disease , 2014, Neurobiology of Aging.
[28] Kristine Yaffe,et al. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.
[29] Jiming Liu,et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.
[30] Xifei Yang,et al. CHRONIC COPPER EXPOSURE CAUSES SPATIAL MEMORY IMPAIRMENT, SELECTIVE LOSS OF HIPPOCAMPAL SYNAPTIC PROTEINS, AND ACTIVATION OF PKR/EIF2 α PATHWAY IN MICE , 2014, Alzheimer's & Dementia.
[31] Nick C Fox,et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.
[32] P. Faller,et al. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles. , 2014, Accounts of chemical research.
[33] P. Pasqualetti,et al. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease , 2014, Annals of neurology.
[34] P. Pasqualetti,et al. Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson’s disease and in hepatic encephalopathy , 2014, Journal of Neural Transmission.
[35] Dong-Woo Lee,et al. Elevated serum copper and ceruloplasmin levels in Alzheimer's disease , 2014, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.
[36] P. Pasqualetti,et al. Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[37] G. Perry,et al. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis , 2013, Neurobiology of Disease.
[38] M. Noroozian,et al. Serum Multivalent Cationic Pattern: Speculation on the Efficient Approach for Detection of Alzheimer's Disease , 2013, Scientific Reports.
[39] R. Deane,et al. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance , 2013, Proceedings of the National Academy of Sciences.
[40] P. Rossini,et al. Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease. , 2013, Rejuvenation research.
[41] Magda I. Mohamad,et al. Histone Deacetylases Enzyme, Copper, and IL-8 Levels in Patients With Alzheimer’s Disease , 2013, American journal of Alzheimer's disease and other dementias.
[42] P. Pasqualetti,et al. Metal-score as a potential non-invasive diagnostic test for Alzheimer's disease. , 2013, Current Alzheimer research.
[43] Dzintra Celmins,et al. Evaluation of a Prototype Point-of-care Instrument Based on Monochromatic X-Ray Fluorescence Spectrometry: Potential for Monitoring Trace Element Status of Subjects with Neurodegenerative Disease , 2012, Journal of toxicology and environmental health. Part A.
[44] D. Selkoe,et al. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[45] I. Tooyama,et al. Transition metal abnormalities in progressive dementias , 2012, BioMetals.
[46] W. Stremmel,et al. EASL Clinical Practice Guidelines: Wilson's disease. , 2012, Journal of hepatology.
[47] C. Masters,et al. Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. , 2012, Free radical biology & medicine.
[48] M. Esiri,et al. Aluminium, iron and copper in human brain tissues donated to the Medical Research Council's Cognitive Function and Ageing Study. , 2012, Metallomics : integrated biometal science.
[49] K. Yaffe,et al. The projected effect of risk factor reduction on Alzheimer's disease prevalence , 2011, The Lancet Neurology.
[50] Mark A. Smith,et al. Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion , 2011, Progress in Neurobiology.
[51] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[52] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[53] N. Delibaş,et al. Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. , 2010, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[54] N. Arnal,et al. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives , 2010, Brain Research.
[55] P. Pasqualetti,et al. Longitudinal prognostic value of serum “free” copper in patients with Alzheimer disease , 2009, Neurology.
[56] S. Kushwaha,et al. Serum copper in Alzheimer’s disease and vascular dementia , 2008, Indian Journal of Clinical Biochemistry.
[57] Ashley I. Bush,et al. Therapeutics for Alzheimer’s disease based on the metal hypothesis , 2008, Neurotherapeutics.
[58] P. Rossini,et al. An observational study on the influence of the APOE-ε4 allele on the correlation between ‘free’ copper toxicosis and EEG activity in Alzheimer disease , 2008, Brain Research.
[59] M. Schilsky,et al. Diagnosis and treatment of Wilson disease: An update , 2008, Hepatology.
[60] E. Londos,et al. Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease , 2008, Dementia and Geriatric Cognitive Disorders.
[61] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[62] Harry V. Vinters,et al. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias , 2007, Neuroscience Letters.
[63] P. Stanzione,et al. Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis. , 2007, Neurotoxicology.
[64] Keiichiro Suzuki,et al. Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats. , 2006, Biochemical and biophysical research communications.
[65] V. Haroutunian,et al. Elevated cortical zinc in Alzheimer disease , 2006, Neurology.
[66] A. Wierzbicki,et al. Copper:caeruloplasmin ratio , 2006, Journal of Clinical Pathology.
[67] S. Brenner. Excess of serum copper not related to ceruloplasmin in Alzheimer disease , 2006, Neurology.
[68] P. Rossini,et al. Ceruloplasmin (2-D PAGE) Pattern and Copper Content in Serum and Brain of Alzheimer Disease Patients , 2006, Biomarker insights.
[69] I. Hozo,et al. Estimating the mean and variance from the median, range, and the size of a sample , 2005, BMC medical research methodology.
[70] S. Brenner. Elevation of serum copper levels in Alzheimer’s disease , 2003, Neurology.
[71] J. Walshe,et al. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically , 2003, Annals of clinical biochemistry.
[72] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[73] Arroyo,et al. Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers* , 1999, European journal of clinical investigation.
[74] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[75] P. Lewitt,et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders , 1996, Brain Research.
[76] W. D. Ehmann,et al. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.
[77] W. Markesbery. Trace Elements In Alzheimer’s Disease , 1996, Alzheimer’s Disease.
[78] W. D. Ehmann,et al. RNAA for arsenic, cadmium, copper, and molybdenum in CNS tissues from subjects with age-related neurodegenerative diseases , 1994 .
[79] A. Noma,et al. Sensitive, direct colorimetric assay for copper in serum. , 1989, Clinical chemistry.
[80] K. Kristensson,et al. Trace elements in the human central nervous system studied with neutron activation analysis , 1987, Biological Trace Element Research.
[81] N. Ward,et al. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease , 1987 .
[82] D. Gajdusek,et al. Studies on Amyotrophic Lateral Sclerosis by Neutron Activation Analysis‐2. Comparative Study of Analytical Results on Guam PD, Japanese ALS and Alzheimer Disease Cases , 1980, Folia psychiatrica et neurologica japonica.
[83] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[84] M. Beeler,et al. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. , 1974, Clinical chemistry.
[85] N. Colabufo,et al. Copper dyshomeostasis in Wilson disease and Alzheimer's disease as shown by serum and urine copper indicators. , 2018, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[86] P. Pasqualetti,et al. Association Between Serum Ceruloplasmin Specific Activity and Risk of Alzheimer's Disease. , 2016, Journal of Alzheimer's disease : JAD.
[87] Jia Sun,et al. Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses. , 2015, Journal of Alzheimer's disease : JAD.
[88] P. Rossini,et al. Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer’s Disease: a Genetic Study of ATP7B Frequency , 2015, Molecular Neurobiology.
[89] Xifei Yang,et al. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis. , 2015, Journal of Alzheimer's disease : JAD.
[90] C. Tormo,et al. Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. , 2013, Journal of Alzheimer's disease : JAD.
[91] Blaine R. Roberts,et al. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[92] M. Muckenthaler,et al. Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment. , 2012, Journal of Alzheimer's disease : JAD.
[93] F. Giubilei,et al. Monitoring of chemical elements and oxidative damage in patients affected by Alzheimer's disease. , 2005, Annali dell'Istituto superiore di sanita.
[94] G. Reynolds,et al. Hippocampal tin, aluminum and zinc in Alzheimer's disease , 2004, Biometals.
[95] A. Passaro,et al. Trace elements and cognitive impairment: an elderly cohort study. , 2004, Archives of gerontology and geriatrics. Supplement.
[96] M. Gerotto,et al. Plasma microelement analysis from Alzheimer’s and multi-infartual dementia patients , 1993 .
[97] B. Winblad,et al. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. , 1991, Journal of neural transmission. Parkinson's disease and dementia section.
[98] P. Wolf. Ceruloplasmin: methods and clinical use. , 1982, Critical reviews in clinical laboratory sciences.